Gazepov, Strahil and Iljaz, Ismaili and Goshevska Dashtevska, Emilija (2016) Unwanted side effects of travoprost. International scientific on-line journal "Science & Technologies", VI (1). pp. 357-365. ISSN 1314-4111
Preview |
Text
1627.pdf Download (977kB) | Preview |
Abstract
Introduction: Glaucoma is a chronical progressive optical neuropathy with characteristic morphological
changes on the desk of the optical nerve and retinal neurofibrillary layer as well as progressive death of
ganglion cells with loss of sight in the absence of other eye diseases and congenital anomalies. It is called
(EGC 2014) in the newest definition from the European association for Glaucoma. The basic medication
for treatment of this illness are the prostaglandin derivatives from which the travoprost is the latest in a
series of derivatives.
Goal: Discovering the unwanted side effects of Travoprost
Discussion: The latest estimates of WHO (World health organization) are the on a global level cancer
takes the first position, the cardiovascular illnesses second and blindness takes the third position as global
challenges that should be addressed. The Glaucoma impacts 9-12% of the people that have blindness in
the world, i.e. 2,5 million people every year. WHO predicts that the percentage with rise to 30% by the
year 2020. From this the need for daily findings of new medication for suppressing this illness occurs.
Conclusion: In the conclusion we can say that the right and on time diagnosis of the glaucoma and the
effective treatment is the only mechanism in the fight with this illness.
Although there are side effects, the travoprost today is one of the basic agents in the fight with Glaucoma.
| Item Type: | Article |
|---|---|
| Subjects: | Medical and Health Sciences > Health sciences |
| Divisions: | Faculty of Medical Science |
| Depositing User: | Strahil Gazepov |
| Date Deposited: | 27 Mar 2017 12:34 |
| Last Modified: | 11 May 2017 07:13 |
| URI: | https://eprints.ugd.edu.mk/id/eprint/17628 |
Actions (login required)
 |
View Item |